Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Vaccine

‘Off the charts’: the key breakthroughs giving new hope in treating cancer

World’s largest cancer conference in Chicago shares ‘impressive’ findings in vaccines, drug trials and AI

The Guardian - UK

COVID vaccines saved millions of lives – linking them to excess deaths is a mistake

A recent study has sparked another round of headlines claiming that COVID vaccines caused excess deaths. This was accompanied by a predictable outpouring of I-told-you-sos on social media.

The Conversation

Three more babies die after developing whooping cough, says UKHSA

Total of eight infants have died from the disease this year, as experts urge pregnant women to get vaccinated

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines

Government advisers say it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall

The Independent UK

FLiRTing with a COVID summer surge? What to know about the newest family of Omicron subvariants

These JN.1 spinoffs are more immune-evasive than subvariants past, scientists say.

Fortune

From immunotherapy to mRNA vaccines – the latest science on melanoma treatment explained

More than 16,000 Australians will be diagnosed with melanoma each year. Most of these will be caught early, and can be cured by surgery.

The Conversation

This virus nearly killed the AMA chief's son. Yet vaccines remain out of reach

His son, Tim, was afflicted with the virus as a toddler.

The Canberra Times

Read news from The Economist, FT, and more,
with one subscription

First Thing: Biden to issue order on new restrictions at US-Mexico border

President’s move comes amid voter dissatisfaction over migration, while progressive and Latino lawmakers express alarm. Plus, world’s first personalized cancer vaccine halves the risk of death from melanoma

The Guardian - UK

Mpox is on the rise in Australia. Here’s what to know about the virus – and who should get vaccinated

Australia appears to be experiencing a re-emergence of the infectious disease mpox, formerly called monkeypox.

The Conversation

Doctor who claimed COVID vaccines made people magnets is sued for ‘failing to pay $650K in taxes’

Dr Sherri Tenpenny had her medical license revoked in 2023, but it was reinstated earlier this year

The Independent UK

‘Extremely impressive’: melanoma jab trial results excite doctors

Vaccine approach will help improve survival rates for ‘the next decades and more’, says Cancer Research UK’s chief clinician

The Guardian - UK

Dr. Fauci To Reevaluate Vaccine Mandate Cost-Benefit Ratio

Dr. Fauci emphasizes evaluating US pandemic response, considering cost-benefit of vaccine mandates, and defending vaccine efficacy.

Top News

Bird flu vaccines face a problem: eggs

Fertilized hen eggs are still the main ingredient in making vaccines that may protect us against H5N1

Salon

Scientists are testing mRNA vaccines to protect cows and people against bird flu

The bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA vaccines — akin to the shots deployed during the COVID-19 pandemic

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

What is the cancer vaccine? NHS patients to be offered trial of personalised jabs

The new cancer vaccine scheme is the first of its kind in the world

The Independent UK

Thousands of NHS patients to trial new personalised cancer vaccine in ‘landmark moment’

Thousands of patients will be recruited to take part in trials over the next year, NHS national clinical director says

Medical Daily

Guillain-Barre Syndrome 'More Common Than Expected' In RSV Vaccinated Older Adults: CDC

While the U.S. Food and Drug Administration (FDA) and the officials from the CDC continue to investigate the risks, the current recommendation is to continue the vaccine as "the estimated benefits of RSV vaccination continued to outweigh potential risks."

The Guardian - UK

What are cancer vaccines and have scientists finally found a cure?

The NHS in England is recruiting for the first large-scale trial of its kind, with hopes high that the personalised jabs could be a gamechanger

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

NHS patients in England to be offered trials for world-first cancer vaccine

Jab personalised for individual’s tumours hailed as ‘gamechanger’ amid high hopes of stopping disease returning

Barchart

Is This Biotech Stock's OpenAI Partnership a Game-Changer?

With AI making waves in biotech, could this biotech’s OpenAI partnership be the catalyst for new highs?

Top News

CDC Reports Rare Nervous System Disorder In RSV Vaccine

CDC reports increased Guillain-Barre syndrome cases in older adults post-RSV vaccination, emphasizing benefits outweigh risks.

The Independent UK

Guillain-Barre syndrome 'more common than expected' with RSV vaccine in older people, CDC reiterates

Reports of a rare nervous system disorder are “more common than expected” in older U.S. adults who got the new RSV vaccines

Reason

The COVID-19 Vaccines Shouldn't Have Been Free

So many problems would have disappeared if we had treated them like a normal product.

Evening Standard

Covid 'universal antibody cocktail' could treat every variant of virus

Scientists hope to create a vaccine that could work against every strain of the virus

LiveScience

Whooping cough outbreaks: Why is pertussis on the rise in several countries?

Notable outbreaks of whooping cough, or pertussis, have raised concern in some countries.

1 … 111 112 113 114

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

the World Health Organization

764 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.